Publication | Open Access
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer
12
Citations
21
References
2012
Year
The sequential anthracycline-taxane regimen is a well-tolerated and feasible alternative to FEC120 therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1